This text is a result of machine translation.
Capital group, an asset management institution, launched ETF products for the first time: buying Chinese stocks such as Guizhou Maotai, Yaoming biology and meituan
Revenue and Net Profit of Wuxi Apptec Both Increased in 2020
Wuxi apptec said that the main reasons for the company's performance growth were the high growth of laboratories in China and the year-on-year growth of CDMO plate. China laboratory service is the core business of Wuxi apptec, accounting for more than 50% of its revenue. Its main business is small molecule drug discovery, drug analysis and testing.
Mar 31, 2021 11:38 AM
Tianci materials: the net profit in the first two months increased by about 470% year-on-year
Baidu responded that it was unable to search "referee document network": caused by misoperation of the technical team
Going Beyond Flat: Kandao QooCam EGO Transcends 'Metaverse' into the Real World
May 25, 2022 02:28 AM